American College of Cardiology Vice President Cathie Biga spoke to Cardiovascular Business about why the organization wants to get more involved in the business side of cardiology.

Medtronic acquired the technology in a 2022 deal reportedly worth $925 million.

The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

A team of specialists examined new outcomes data related to the SAPIEN 3 Ultra transcatheter heart valve, sharing its findings in EuroIntervention.

Steven Nissen, MD, spoke with Cardiovascular Business at ACC.23 about the late-breaking CLEAR Outcomes trial.

The popular diet appears to benefit women even more than it benefits men. 

New research, presented during ACC.23/WCC in New Orleans, has raised fresh concerns about the potential cardiovascular-related drawbacks of high-fat, low-carbohydrate diets. 

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

When human counselors are unavailable to provide work-based wellness coaching, robots can substitute—as long as the workers are comfortable with emerging technologies and the machines aren’t overly humanlike.